Small-molecule inhibitor of influenza virus
An influenza virus and inhibitor technology, applied in the field of influenza virus small molecule inhibitors, can solve the problem of easy mutation and drug resistance of influenza virus and other problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Embodiment 1, the inhibitory efficacy evaluation of pralatrexate
[0029] 1. Evaluation of the inhibitory effect of pralatrexate on H1N1 influenza virus by multi-concentration gradient experiments at the cell level
[0030] 1. Add dual antibodies (penicillin and streptomycin) and TPCK (final concentration: 2 μg / ml) to the DMEM medium to prepare a maintenance solution, and use this maintenance solution to dilute the influenza virus so that the titer of the influenza virus is 100 TCID 50 / 25μl maintenance solution.
[0031] 2. Dissolve pralatrexate with 100% DMSO and prepare a 40mM mother solution, then use the maintenance solution prepared in step 1 to dilute the mother solution 5 times in a gradient to different concentrations (100 μM, 20 μM, 4 μM, 0.8 μM, 0.16 μM, 0.032μM, 0.0064μM, 0.00128μM, 0.000256μM, 0.0000512μM) solutions to be tested, each concentration volume is 50ul. The final concentration of DMSO in the test solution was 0.02% (volume percentage), and a ne...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com